Skip to main content
. 2022 Jun 21;2022(6):CD006404. doi: 10.1002/14651858.CD006404.pub4

1.11. Analysis.

1.11

Comparison 1: Pyronaridine‐artesunate versus artemether‐lumefantrine, Outcome 11: Subsequent treatment(s), ALT increase > 5 × ULN